AGREEMENTStockholder Agreement • April 20th, 2015 • Leap Tide Capital Management, LLC • Pharmaceutical preparations • California
This agreement, effective April 16, 2015 (this “Agreement”), is made by and among Leap Tide Capital Management, LLC, and Jan Loeb (each, a “Leap Tide Stockholder,” and collectively, the “Leap Tide Group”), and DiaDEXUS, Inc. (“DiaDEXUS” or the “Company”). In consideration of and in reliance upon the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
JOINT FILING AGREEMENTJoint Filing Agreement • October 27th, 2014 • Leap Tide Capital Management, LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.01 par value, of diaDexus, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • January 31st, 2012 • Leap Tide Capital Management, LLC • Miscellaneous manufacturing industries
The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of Common Stock of Kid Brands, Inc. dated as of January 31, 2012, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(c) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • October 31st, 2012 • Leap Tide Capital Management, LLC • Surgical & medical instruments & apparatus
The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of Common Stock of InfuSystem Holdings, Inc. dated as of October 26, 2012, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(c) under the Securities Exchange Act of 1934.
